Characteristic | Value (mean ± SD) | |
---|---|---|
Age (years), mean ± SD | 54.86 ± 8.3 | |
ADC* | 1.5 ± 0.2 | |
Gender (no., %) | Male Female | 16 (32%) 34 (68%) |
Tumor size (no., %) | ≤ 4 cm > 4 cm | 13 (26%) 37 (74%) |
Tissue component (no., %) | Solid Mixed (cystic/necrotic) | 34 (68%) 16 (32%) |
Unenhanced T1 | Hypointense Isointense | 33 (66%) 17 (34%) |
Tumor histology (no., %) | Clear-cell carcinoma Non-clear-cell carcinoma | 28 (56%) 22 (44%) |
Growth pattern (no., %) | Infiltrative Cortical | 26 (52%) 24 (48%) |
Clinical stage | Low-stage (1 and II) High-stage (III and IV) | 29 (58%) 21 (42%) |
Lymph node metastasis | Yes No | 21 (42%) 29 (58%) |
Tumor grade (no., %) | I II III IV | 24 (48%) 5 (10%) 16 (32%) 5 (10%) |